P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

April 2005

Features

Editorial Board Spotlight

Ramblin’ Ransom: Reviewer, Writer, and Researcher

P&T’s Seattle-based neurologist, Bruce R. Ransom, is savvy, slightly sardonic, and—oh yes—smart.
Sonja Sherritze

Letter to the Editor

Triptan Use in the Real World

The use of the two-hour efficacy time point in evaluating triptans is debated.
Richard White, PhD, MPH

Meeting Highlights

54th Scientific Session, American College of Cardiology

Lawrence and Sharon Prescott review some new therapies for atherosclerosis, coronary artery disease, hypertension, myocardial infarction, acute coronary syndrome, stroke, and heart failure
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Agalsidase beta: Enzyme Replacement Therapy for Fabry Disease

The authors discuss a recombinant product (Fabrazyme®) for the treatment of a rare disorder caused by an enzyme deficiency.
Julie A. Aaron, PharmD, and Nicole T. Ansani, PharmD

Pharmaceutical-Approval Update: Oncology

The author discusses recent FDA approvals for doxorubicin HCl liposome injection (Doxil®) for patients with ovarian cancer, paclitaxel protein-bound particles for injectable suspension (Abraxane™) for the treatment of breast cancer, and erlotinib (Tarceva®) therapy for patients with non–small cell lung cancer.
Marvin M. Goldenberg, PhD, RPh, MS

Continuing Education Credit

Movement Disorders: Overview and Treatment Options

The authors review therapies for essential tremor, Parkinson’s disease, dystonia, myoclonus, chorea, tic disorders, tardive dyskinesia and akasthisia, restless limbs syndrome, and Wilson’s disease.
Ali Samii, MD, and Bruce R. Ransom, MD, PhD

Departments

Editorial

Give PEACE a Chance

David Nash, MD, MBA, discusses PEACE, a P&T subcommittee set up to contain formulary costs.
David Nash, MD, MBA

Medication Errors

Erroneous Dosing of Oral Methotrexate

Matthew Grissinger, RPh, FASCP, explains the special precautions required to avoid errors in methotrexate administration.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Ban-Busting Bill: Senate May Pass Legislation Permitting Drug Importation

Stephen Barlas discusses the factors that might lead Congress to authorize drug importation.
Stephen Barlas

Drug Forecast

Sculptra™: A Novel Treatment Approach for HIV-Associated Facial Lipoatrophy

Drs. Marzella and Antonopoulos review an injectable product, poly-l-lactic acid (Sculptra™), for patients with HIV-associated facial lipoatrophy.
Nino Marzella, BS, PharmD, and Marilena S. Antonopoulos, PharmD

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.